COVID-19 Testing for Pregnancy (STOPCOVID19 Trial)

Palo Alto (17 mi)

Overseen byMegan E Foeller, MD

Age: Any Age

Sex: Female

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: Washington University School of Medicine

Trial Summary

What is the purpose of this trial?This trial aims to understand how COVID-19 affects pregnant women by checking their health and observing their well-being over time. It will help improve testing strategies and prenatal care plans to better support pregnant women during the pandemic.

Eligibility Criteria

This trial is for pregnant women without prior SARS-CoV-2 infection (unexposed group) and those with a viable pregnancy who have tested positive or developed antibodies during their current pregnancy (exposed group). Women with no viable intrauterine pregnancy or evidence of previous COVID-19 immunity are excluded.

Treatment Details

The study tests for the presence of SARS-CoV-2 through RNA, IgM, and IgG antibody testing in pregnant women. It aims to understand the necessity of asymptomatic disease testing in pregnancy and its impact on prenatal care plans.

2Treatment groups

Active Control

Placebo Group

Group I: Exposed (SARS-CoV-2 positive) cohortActive Control2 Interventions

Women who experience laboratory-confirmed SARS-CoV-2 infection during pregnancy.

Group II: Unexposed (SARS-CoV-2 negative) cohortPlacebo Group1 Intervention

Women who do not experience laboratory-confirmed SARS-CoV-2 infection during pregnancy.